- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CC-486 (ORAL AZACITIDINE)
Total 7308 results
-
CelgeneApproved for marketing
-
CelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, United Kingdom
-
University of FlorenceActive, not recruiting
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Groupe Francophone des MyelodysplasiesBristol-Myers Squibb; AbbVieRecruitingUntreated Myelodysplastic SyndromeFrance
-
CelgeneCompletedMyelodysplastic Syndromes (MDS) | Chronic Myelomonocytic Leukemia (CMML) | Acute Myelogenous Leukemia (AML)United States
-
Kirby InstituteCelgeneCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
CelgeneCompletedNasopharyngeal NeoplasmsCanada, United States, Taiwan, France, Spain, Greece, Italy, Singapore, Tunisia
-
CelgeneActive, not recruiting
-
Bristol-Myers SquibbRecruitingHepatic Insufficiency | NeoplasmsSpain, United States, Germany, Argentina, Colombia, Greece
-
CelgeneActive, not recruitingNeoplasms | Hematologic Malignancies | Hematologic NeoplasmUnited Kingdom, United States
-
Yale UniversityBristol-Myers Squibb; National Cancer Institute (NCI)WithdrawnAcute Myeloid LeukemiaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedPreviously Untreated Peripheral T-cell LymphomaUnited States
-
Bristol-Myers SquibbRecruiting
-
AbbVieRoche-GenentechActive, not recruitingAcute Myeloid Leukemia (AML)United States, Australia, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
CelgeneActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Italy, France, Germany, Greece, Spain
-
Translational Research in OncologyCelgeneTerminatedEpithelial Ovarian CancerUnited States
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, United Kingdom, Australia, Poland, Spain, Belgium, Italy, Germany, France, Canada
-
CelgeneAbbVieCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationRecruitingAML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
University of ChicagoTerminatedFollicular LymphomaUnited States
-
The Lymphoma Academic Research OrganisationCelgeneActive, not recruitingRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaFrance, Denmark, United Kingdom, Austria, Belgium
-
University of BirminghamActive, not recruitingAcute Myeloid Leukemia | MyelodysplasiaUnited Kingdom
-
John ReneauBristol-Myers SquibbRecruitingT-Cell Large Granular Lymphocyte LeukemiaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Celgene CorporationCompletedColorectal CancerUnited States
-
CelgeneTerminatedBreast NeoplasmsSpain, United States, Belgium, Italy, France, Germany
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedPancreatic CancerUnited States
-
Medical University of South CarolinaCelgene CorporationCompletedLarge B-Cell Diffuse LymphomaUnited States
-
CelgeneCompletedCarcinoma, Non-Small-Cell LungUnited States, Canada, France, Germany, Italy, Spain, United Kingdom
-
National Cancer Institute (NCI)WithdrawnHepatosplenic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Adult T-cell Leukemia/Lymphoma | Extranodal NK-/T-cell Lymphoma, Nasal Type | Monomorphic Epiteliotrophic Intestinal T-cell LymphomaUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
CelgeneActive, not recruitingLeukemia, Myeloid, AcuteUnited States, Australia, Brazil, Canada, Czechia, Finland, France, Germany, Italy, Korea, Republic of, Mexico, Portugal, Russian Federation, Spain, United Kingdom, Belgium, Taiwan, Austria, Ireland, Israel, Lithuania, Poland, Turkey
-
University Health Network, TorontoCompletedMicrosatellite Stable Colorectal Carcinoma | Platinum Resistant Epithelial Ovarian Cancer Type II | Estrogen Receptor Positive and HER2 Negative Breast CancerCanada
-
Bristol-Myers SquibbRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
CelgeneCompletedCarcinoma, Non-Small-Cell Lung | Urinary Bladder Neoplasms | Tumor Virus Infections | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Transitional Cell | Carcinoma, Pancreatic DuctalSpain, United States, France, Netherlands
-
CelgeneCompletedMelanoma | Sarcoma | Neoplasms | Lymphoma | Renal Cell Carcinoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Breast Cancer | Small Cell Lung Cancer | Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Non-Small Cell Lung Cancer | Osteosarcoma | Glioblastoma Multiforme | Metastatic Breast... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; CelgeneActive, not recruitingMetastatic Melanoma | Melanoma and Other Malignant Neoplasms of SkinUnited States
-
University of Colorado, DenverBristol-Myers SquibbRecruiting
-
Ege UniversityCompletedEnd-stage Renal DiseaseTurkey
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; Celgene; Stand Up To Cancer; Syndax Pharmaceuticals; Rhone-Poulenc... and other collaboratorsCompletedNon-Small Cell Lung Cancer | Epigenetic TherapyUnited States
-
CelgeneCompletedLymphoma, Follicular | Lymphoma, Large B-Cell, DiffuseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAngioimmunoblastic T-cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | Follicular T-Cell Lymphoma | Nodal Peripheral T-Cell Lymphoma...United States
-
Joseph TuscanoNational Cancer Institute (NCI); CelgeneActive, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingLymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditionsUnited States
-
Nanfang Hospital of Southern Medical UniversityThe Affiliated Hospital of Qingdao University; Sun Yat-Sen Memorial Hospital... and other collaboratorsRecruitingVenetoclax Combined With Azacitidine Plus Homoharringtonine | Venetoclax Combined With AzacitidineChina
-
Aprea TherapeuticsCompletedMyeloid MalignancyUnited States
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States